000 01338 a2200361 4500
005 20250517061042.0
264 0 _c20160915
008 201609s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/1381612821666151027152534
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGonzález-Fernández, Yolanda
245 0 0 _aAntitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2015
300 _a6104-24 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aChild
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Carriers
_xchemistry
650 0 4 _aDrug Delivery Systems
650 0 4 _aHumans
650 0 4 _aLipids
_xchemistry
650 0 4 _aNanoparticles
650 0 4 _aOsteosarcoma
_xdrug therapy
700 1 _aImbuluzqueta, Edurne
700 1 _aPatiño-García, Ana
700 1 _aBlanco-Prieto, María J
773 0 _tCurrent pharmaceutical design
_gvol. 21
_gno. 42
_gp. 6104-24
856 4 0 _uhttps://doi.org/10.2174/1381612821666151027152534
_zAvailable from publisher's website
999 _c25389065
_d25389065